Form 4: Pfizer Executive Vice President Acquires Phantom Stock Units
SEC Form 4 Filing
Pfizer's Executive Vice President, Rady A. Johnson, acquired 7 phantom stock units through the company's Supplemental Savings Plan.
Summary
- Rady A. Johnson, an Executive Vice President at Pfizer, acquired 7 phantom stock units on November 29, 2024.
- These units were obtained through the Pfizer Supplemental Savings Plan.
- Each unit represents one phantom share of Pfizer common stock.
- The units will be settled in cash following Mr. Johnson's separation from service.
- Mr. Johnson has the option to transfer these units into an alternative investment account at any time.
- Following this transaction, Mr. Johnson directly owns 9,363 phantom stock units.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to executive compensation, which is generally viewed neutrally to slightly positive as it aligns executive interests with company performance.
Positives
- The acquisition of phantom stock units by a high-ranking executive may signal confidence in the company's future performance.
Future Outlook
The phantom stock units will be settled in cash upon the reporting person's separation from service, or can be transferred to an alternative investment account at any time.
Industry Context
This is a routine filing related to executive compensation and is common practice for publicly traded companies like Pfizer. It reflects the company's use of equity-based compensation to align executive interests with shareholder value.
Comparison to Industry Standards
- Many large pharmaceutical companies use phantom stock units as part of their executive compensation packages.
- These units are often tied to performance metrics and are designed to incentivize long-term value creation.
- Companies like Johnson & Johnson and Merck also utilize similar compensation structures for their executives.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns executive interests with company performance.
Key Dates
| Date | Description |
|---|---|
| 11/29/2024 | Date of the transaction where Rady A. Johnson acquired phantom stock units. |
| 12/02/2024 | Date the form was signed by Susan E. Grant, by power of atty., for Rady A. Johnson. |
Keywords
Pfizer, phantom stock units, executive compensation, insider trading, supplemental savings plan, Rady A. Johnson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.